ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 3 filers reported holding ACASTI PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $4,000 | -33.3% | 5,000 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $6,000 | 0.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $6,000 | -40.0% | 5,000 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $10,000 | -54.5% | 5,000 | -87.5% | 0.00% | -50.0% |
Q2 2021 | $22,000 | -8.3% | 40,000 | 0.0% | 0.01% | -25.0% |
Q1 2021 | $24,000 | +84.6% | 40,000 | 0.0% | 0.01% | +100.0% |
Q4 2020 | $13,000 | +62.5% | 40,000 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $8,000 | -55.6% | 40,000 | 0.0% | 0.00% | -57.1% |
Q2 2020 | $18,000 | +20.0% | 40,000 | 0.0% | 0.01% | -12.5% |
Q1 2020 | $15,000 | -69.4% | 40,000 | +100.0% | 0.01% | -65.2% |
Q4 2019 | $49,000 | +28.9% | 20,000 | 0.0% | 0.02% | +21.1% |
Q3 2019 | $38,000 | – | 20,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 236,559 | $594,000 | 0.04% |
INTACT INVESTMENT MANAGEMENT INC. | 89,490 | $287,000 | 0.01% |
BANK OF MONTREAL /CAN/ | 210,484 | $537,000 | 0.00% |
DEUTSCHE BANK AG\ | 215 | $0 | 0.00% |
Tower Research Capital LLC (TRC) | 200 | $1,000 | 0.00% |
CITIGROUP INC | 30 | $0 | 0.00% |
MORGAN STANLEY | 18 | $0 | 0.00% |
Renaissance Technologies | 20,900 | $53,000 | 0.00% |
ROYAL BANK OF CANADA | 588 | $1,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 400 | $1,000 | 0.00% |